Literature DB >> 16251989

Nicotine addiction and comorbidity with alcohol abuse and mental illness.

John A Dani1, R Adron Harris.   

Abstract

The World Health Organization estimates that one-third of the global adult population smokes. Because tobacco use is on the rise in developing countries, death resulting from tobacco use continues to rise. Nicotine, the main addictive component of tobacco, initiates synaptic and cellular changes that underlie the motivational and behavioral alterations that culminate in addiction. Nicotine addiction progresses rapidly in adolescents and is most highly expressed in vulnerable people who have psychiatric illness or other substance abuse problems.

Entities:  

Mesh:

Year:  2005        PMID: 16251989     DOI: 10.1038/nn1580

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  152 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Alcohol use predicts ER visits in individuals with alpha-1 antitrypsin deficiency (AATD) associated COPD.

Authors:  Karin F Hoth; Dee W Ford; Robert A Sandhaus; Charlie Strange; Frederick S Wamboldt; Kristen E Holm
Journal:  COPD       Date:  2012-05-31       Impact factor: 2.409

3.  Using propensity score modeling to minimize the influence of confounding risks related to prenatal tobacco exposure.

Authors:  Hua Fang; Craig Johnson; Nicolas Chevalier; Christian Stopp; Sandra Wiebe; Lauren S Wakschlag; Kimberly Andrews Espy
Journal:  Nicotine Tob Res       Date:  2010-10-28       Impact factor: 4.244

Review 4.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

5.  Chronic nicotine treatment differentially modifies acute nicotine and alcohol actions on GABA(A) and glutamate receptors in hippocampal brain slices.

Authors:  William R Proctor; Peter Dobelis; Anna T Moritz; Peter H Wu
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 6.  Unique, long-term effects of nicotine on adolescent brain.

Authors:  Frances M Leslie
Journal:  Pharmacol Biochem Behav       Date:  2020-07-30       Impact factor: 3.533

7.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

Review 8.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders.

Authors:  Andrea H Weinberger; Rani A Desai; Sherry A McKee
Journal:  Drug Alcohol Depend       Date:  2009-12-16       Impact factor: 4.492

10.  Coadministration of intravenous nicotine and oral alcohol in rats.

Authors:  A D Lê; Steven Lo; Stephen Harding; Walter Juzytsch; Peter W Marinelli; Douglas Funk
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.